Millipore Sigma Vibrant Logo

OP14L Anti-c-ErbB2/c-Neu (Ab-2) Mouse mAb (9G6)

Anti-c-ErbB2/c-Neu (Ab-2), mouse monoclonal, clone 9G6, recognizes the ~185 kDa c-ErbB2/c-Neu SK-BR-3 cells and breast carcinoma. It is validated for IP and IHC on frozen and paraffin sections.

Anti-c-ErbB2/c-Neu (Ab-2) Mouse mAb (9G6): Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: Anti-Neu, Anti-ErbB2, Anti-Erythroblastosis Virus, Anti-HER2

View Products on Sigmaaldrich.com
OP14L
Ver precios y disponibilidad

Descripción

Replacement Information

Tabla espec. clave

Species ReactivityHostAntibody Type
HMMonoclonal Antibody

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
OP14L-100UG
Comprobando disponibilidad...
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      		 Frasco de vidrio 100 μg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      —
      Solicitar precio
      		 —
      Description
      OverviewRecognizes the ~185 kDa c-ErbB2/c-Neu in SK-BR-3 cells and breast carcinoma tissue. Does not cross-react with v-ErbB2 or the EGF receptor.
      Catalogue NumberOP14L
      Brand Family Calbiochem®
      SynonymsAnti-Neu, Anti-ErbB2, Anti-Erythroblastosis Virus, Anti-HER2
      References
      ReferencesVan De Vijver, M.J., et al.1988 New Engl. J. Med. 319, 1239.
      DiFiore, P.P., et al.1987 Science 237, 178.
      Slamon, D.J., et al. 1987 Science 235, 177.
      Varley, J.M., et al.1987 Oncogene 1, 423.
      Bargmann, C.I., et al. 1986 Nature 319, 226.
      Yamamoto, T., et al.1986 Nature 319, 230.
      Blick, M., et al. 1984 Blood 64, 1234.
      Product Information
      FormLyophilized
      FormulationLyophilized from a volatile buffer, 100 µg BSA.
      Negative controlHepG2 cells or normal skin
      Positive controlSK-BR-3 cells or breast carcinoma tissue
      PreservativeNone
      Quality LevelMQ100
      Applications
      Application ReferencesParaffin Sections Van De Vijver, M.J., et al. 1988. New Engl. J. Med. 319, 1239.
      Key Applications Frozen Sections
      Immunoprecipitation
      Paraffin Sections
      Application NotesFrozen Sections (5 µg/ml)
      Immunoprecipitation (1 µg/sample)
      Paraffin Sections (see application references)
      Application CommentsImmunoprecipitates the ~185 kDa c-neu protein and has been reported to stain formalin-fixed paraffin-embedded tissue sections of human breast carcinomas overexpressing the c-neu protein. This antibody reacts with a cell surface epitope of c-neu but does not cross-react with the EGF receptor. In one study ductal carcinomas in situ displaying large-cell, comedo growth type, were stained while none of 16 ductal carcinomas in situ of small-cell, papillary, or cribiform growth type were stained by this antibody. Antibody should be titrated for optimal results in individual systems.
      Biological Information
      Immunogencells overexpressing human c-ErbB2/c-Neu
      ImmunogenHuman
      Clone9G6
      HostMouse
      IsotypeIgG₁
      Species Reactivity
      • Human
      Antibody TypeMonoclonal Antibody
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Do not freeze Ok to freeze
      Special InstructionsReconstitute the lyophilized antibody with sterile PBS, pH 7.4, or sterile 20 mM Tris-saline (20 mM Tris containing 0.15 M NaCl), pH 7.4, to yield a final concentration of 100 µg/ml. Lyophilized antibodies should be reconstituted at 4°C with occasional gentle mixing for at least 2 h. Following reconstitution, refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage with 0.1% azide. Avoid freeze/thaw cycles of solutions.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      OP14L-100UG 04055977224825

      Documentation

      Anti-c-ErbB2/c-Neu (Ab-2) Mouse mAb (9G6) Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      Anti-c-ErbB2/c-Neu (Ab-2) Mouse mAb (9G6) Certificados de análisis

      CargoNúmero de lote
      OP14L

      Referencias bibliográficas

      Visión general referencias
      Van De Vijver, M.J., et al.1988 New Engl. J. Med. 319, 1239.
      DiFiore, P.P., et al.1987 Science 237, 178.
      Slamon, D.J., et al. 1987 Science 235, 177.
      Varley, J.M., et al.1987 Oncogene 1, 423.
      Bargmann, C.I., et al. 1986 Nature 319, 226.
      Yamamoto, T., et al.1986 Nature 319, 230.
      Blick, M., et al. 1984 Blood 64, 1234.
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision02-October-2007 RFH
      SynonymsAnti-Neu, Anti-ErbB2, Anti-Erythroblastosis Virus, Anti-HER2
      ApplicationFrozen Sections (5 µg/ml)
      Immunoprecipitation (1 µg/sample)
      Paraffin Sections (see application references)
      DescriptionPurified mouse monoclonal antibody generated by immunizing BALB/c mice with the specified immunogen and fusing splenocytes with SP2/0 Ag14 mouse myeloma cells. Recognizes the ~185 kDa c-ErbB2/c-neu protein.
      BackgroundAmplification of the human proto-oncogene c-neu occurs in approximately 30% of breast carcinomas and the amplification maybe a useful predictor of disease prognosis. Gene amplification and the resulting overexpression of proto-oncogene encoded proteins is thought to transform cells by chronically stimulating signal transduction pathways, and in model systems overexpression of human c-neu induces cellular transformation. In the rat model system, a point mutation has been located within the transmembrane domain of the c-neu oncogene. neu (from neuroglioblastomas) is also referred to as erbB-2 (from erythroblastosis virus) and HER2 (for Human Epidermal growth factor Receptor) and is the second member of the EGF receptor family to be described.
      HostMouse
      Immunogen speciesHuman
      Immunogencells overexpressing human c-ErbB2/c-Neu
      Clone9G6
      IsotypeIgG₁
      Specieshuman
      Positive controlSK-BR-3 cells or breast carcinoma tissue
      Negative controlHepG2 cells or normal skin
      FormLyophilized
      FormulationLyophilized from a volatile buffer, 100 µg BSA.
      PreservativeNone
      CommentsImmunoprecipitates the ~185 kDa c-neu protein and has been reported to stain formalin-fixed paraffin-embedded tissue sections of human breast carcinomas overexpressing the c-neu protein. This antibody reacts with a cell surface epitope of c-neu but does not cross-react with the EGF receptor. In one study ductal carcinomas in situ displaying large-cell, comedo growth type, were stained while none of 16 ductal carcinomas in situ of small-cell, papillary, or cribiform growth type were stained by this antibody. Antibody should be titrated for optimal results in individual systems.
      Storage +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsReconstitute the lyophilized antibody with sterile PBS, pH 7.4, or sterile 20 mM Tris-saline (20 mM Tris containing 0.15 M NaCl), pH 7.4, to yield a final concentration of 100 µg/ml. Lyophilized antibodies should be reconstituted at 4°C with occasional gentle mixing for at least 2 h. Following reconstitution, refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage with 0.1% azide. Avoid freeze/thaw cycles of solutions.
      Toxicity Standard Handling
      ReferencesVan De Vijver, M.J., et al.1988 New Engl. J. Med. 319, 1239.
      DiFiore, P.P., et al.1987 Science 237, 178.
      Slamon, D.J., et al. 1987 Science 235, 177.
      Varley, J.M., et al.1987 Oncogene 1, 423.
      Bargmann, C.I., et al. 1986 Nature 319, 226.
      Yamamoto, T., et al.1986 Nature 319, 230.
      Blick, M., et al. 1984 Blood 64, 1234.
      Application referencesParaffin Sections Van De Vijver, M.J., et al. 1988. New Engl. J. Med. 319, 1239.

      Productos y aplicaciones relacionados

      Related Products

      Número de referencia Descripción  
      OP14 Anti-c-ErbB2/c-Neu (Ab-2) Mouse mAb (9G6) Precios y disponibilidad

      Categorías

      Life Science Research > Antibodies and Assays > Primary Antibodies